药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Piclozotan
The risk or severity of adverse effects can be increased when Piclozotan is combined with Levomilnacipran.
Insulin detemir
Carisbamate
The risk or severity of adverse effects can be increased when Carisbamate is combined with Levomilnacipran.
Insulin detemir
Eltanolone
The risk or severity of adverse effects can be increased when Eltanolone is combined with Levomilnacipran.
Insulin detemir
Cerlapirdine
The risk or severity of adverse effects can be increased when Cerlapirdine is combined with Levomilnacipran.
Insulin detemir
Eplivanserin
The risk or severity of adverse effects can be increased when Eplivanserin is combined with Levomilnacipran.
Insulin detemir
Sarpogrelate
The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Levomilnacipran.
Insulin detemir
Vinpocetine
The risk or severity of adverse effects can be increased when Vinpocetine is combined with Levomilnacipran.
Insulin detemir
MK-212
The risk or severity of adverse effects can be increased when MK-212 is combined with Levomilnacipran.
Insulin detemir
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when m-Chlorophenylpiperazine is combined with Levomilnacipran.
Insulin detemir
Imagabalin
The risk or severity of adverse effects can be increased when Imagabalin is combined with Levomilnacipran.
Insulin detemir
Vabicaserin
The risk or severity of adverse effects can be increased when Vabicaserin is combined with Levomilnacipran.
Insulin detemir
Idalopirdine
The risk or severity of adverse effects can be increased when Idalopirdine is combined with Levomilnacipran.
Insulin detemir
Lanicemine
The risk or severity of adverse effects can be increased when Lanicemine is combined with Levomilnacipran.
Insulin detemir
Etiracetam
The risk or severity of adverse effects can be increased when Etiracetam is combined with Levomilnacipran.
Insulin detemir
Brexanolone
The risk or severity of adverse effects can be increased when Brexanolone is combined with Levomilnacipran.
Insulin detemir
Tetrahydrocannabivarin
The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Levomilnacipran.
Insulin detemir
Tropisetron
The risk or severity of adverse effects can be increased when Tropisetron is combined with Levomilnacipran.
Insulin detemir
Iferanserin
The risk or severity of adverse effects can be increased when Iferanserin is combined with Levomilnacipran.
Insulin detemir
Mosapride
The risk or severity of adverse effects can be increased when Mosapride is combined with Levomilnacipran.
Insulin detemir
Thiocolchicoside
The risk or severity of adverse effects can be increased when Thiocolchicoside is combined with Levomilnacipran.